SCHEMBL4932458

SCHEMBL4932458

CCNc1cc(C)cc(COc2c(Cl)cc(C(=O)NCC(=O)O)cc2Cl)c1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
KMT2A Q03164 4/20 0.39
HPGD P15428 3/20 0.39
MEN1 O00255 3/20 0.39
RAB9A P51151 2/20 0.39
GAA P10253 2/20 0.39
LMNA P02545 2/20 0.39
ABL1 P00519 1/20 0.39
MAPT P10636 1/20 0.39
RIN1 Q13671 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KDM4E B2RXH2 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HSD17B10 Q99714 1/20 0.36
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4931285 0.92 ALDH1A1 (0.37) ALDH1A1KMT2AHPGDMEN1RAB9A
SCHEMBL4947897 0.91 KMT2A (0.39) ALDH1A1KMT2AHPGDMEN1RAB9A
SCHEMBL4929941 0.90 SMN1; SMN2 (0.38) ALDH1A1KMT2AHPGDMEN1RAB9A
SCHEMBL4933336 0.90 ALDH1A1 (0.38) ALDH1A1KMT2AHPGDMEN1RAB9A
SCHEMBL4931300 0.89 ALDH1A1 (0.37) ALDH1A1KMT2AHPGDMEN1RAB9A
SCHEMBL5116899 0.88 ALDH1A1 (0.39) ALDH1A1KMT2AHPGDMEN1RAB9A
SCHEMBL5717983 0.88 THRA (0.43) THRB
SCHEMBL5107711 0.88 ALDH1A1 (0.39) ALDH1A1KMT2AHPGDMEN1RAB9A
SCHEMBL5718235 0.87 ALDH1A1 (0.34) ALDH1A1KMT2AHPGDMEN1RAB9A
SCHEMBL4935198 0.87 ALDH1A1 (0.38) ALDH1A1KMT2AHPGDMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA ALDH1A1 1818/4885KMT2A 1742/4885HPGD 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.